These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1994693)

  • 1. Antibody responses to four Haemophilus influenzae type b conjugate vaccines.
    Käyhty H; Eskola J; Peltola H; Rönnberg PR; Kela E; Karanko V; Saarinen L
    Am J Dis Child; 1991 Feb; 145(2):223-7. PubMed ID: 1994693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants.
    Holmes SJ; Fritzell B; Guito KP; Esbenshade JF; Blatter MM; Reisinger KS; Keyserling HL; Rothstein EP; Bernstein HH; Feldman S
    Am J Dis Child; 1993 Aug; 147(8):832-6. PubMed ID: 8352217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
    J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
    N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children.
    Capeding MR; Nohynek H; Käyhty H; Pascual LG; Sunico ES; Tamundong AA; Ruutu P
    Vaccine; 1998; 16(9-10):1004-8. PubMed ID: 9682351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen.
    Bewley KM; Schwab JG; Ballanco GA; Daum RS
    Pediatrics; 1996 Nov; 98(5):898-904. PubMed ID: 8909483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections.
    Kaplan SL; Zahradnik JM; Mason EO; Dukes CM
    J Pediatr; 1988 Aug; 113(2):272-7. PubMed ID: 3260943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide.
    Schneider LC; Insel RA; Howie G; Madore DV; Geha RS
    J Allergy Clin Immunol; 1990 May; 85(5):948-53. PubMed ID: 2332568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants.
    Bulkow LR; Wainwright RB; Letson GW; Chang SJ; Ward JI
    Pediatr Infect Dis J; 1993 Jun; 12(6):484-92. PubMed ID: 8345981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
    Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys.
    Vella PP; Ellis RW
    Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection.
    Steinhoff MC; Auerbach BS; Nelson KE; Vlahov D; Becker RL; Graham NM; Schwartz DH; Lucas AH; Chaisson RE
    N Engl J Med; 1991 Dec; 325(26):1837-42. PubMed ID: 1683682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age.
    Käyhty H; Peltola H; Eskola J; Rönnberg PR; Kela E; Karanko V; Mäkelä PH
    Pediatrics; 1989 Dec; 84(6):995-9. PubMed ID: 2587155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.
    Lepow ML; Samuelson JS; Gordon LK
    J Pediatr; 1985 Feb; 106(2):185-9. PubMed ID: 3871477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antigenuria after immunization with three Haemophilus influenzae type b conjugate vaccines.
    Rothstein EP; Madore DV; Girone JA; Schiller RP; Hipp TJ; Souder RL; Bernstein HH
    Pediatr Infect Dis J; 1991 Apr; 10(4):311-4. PubMed ID: 2062627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.